Par Drugs and Chemicals Limited (NSE:PAR)

Market Cap	1.17B
Revenue (ttm)	1.01B
Net Income (ttm)	133.58M
Shares Out	12.30M
EPS (ttm)	10.86
PE Ratio	8.78
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,495
Average Volume	5,800
Open	95.00
Previous Close	95.34
Day's Range	94.32 - 96.00
52-Week Range	81.01 - 348.45
Beta	-0.39
RSI	39.20
Earnings Date	Aug 1, 2025

About Par Drugs and Chemicals

Par Drugs and Chemicals Limited develops, manufactures, and sells active pharmaceutical ingredients (APIs) and fine chemicals in India. The company provides API products, including magnesium hydroxide, magnesium oxide USP, sucralfate, almagate BP, dried aluminium hydroxide gel, light magnesium carbonate, magaldrate, magnesium trisilicate, colloidal silicon dioxide, aluminium magnesium silicate, magnesium aluminometasilicate, magnesium aluminosilicate-USP, magnesium oxide light, magnesium oxide heavy, magnesium aluminium hydrate, hydrotalcite, a...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1982
• Employees: 122
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: PAR

Financial Performance

In 2024, Par Drugs and Chemicals's revenue was 1.01 billion, an increase of 5.58% compared to the previous year's 956.40 million. Earnings were 133.58 million, a decrease of -7.88%.